SPY375.70-2.76 -0.73%
DIA308.12-1.80 -0.58%
IXIC12,998.50-114.14 -0.87%

Baird Downgrades Amgen to Underperform, Raises Price Target to $185

Baird analyst Brian Skorney downgrades Amgen (NASDAQ:AMGN) from Neutral to Underperform and raises the price target from $173 to $185.

Benzinga · 01/31/2020 11:13

Baird analyst Brian Skorney downgrades Amgen (NASDAQ:AMGN) from Neutral to Underperform and raises the price target from $173 to $185.